You are here

Genevant

Wrong party, wrong court: Moderna fights back against patent infringement case surrounding its Covid-19 vaccine

Endpoints

Mon, 05/9/22 - 11:30 pm

Moderna Therapeutics

lipid nanoparticles

Covid vaccine patent landscape heats up as Pfizer's partner sues Arbutus and Genevant

Endpoints

Mon, 03/21/22 - 10:26 pm

Moderna Therapeutics

Vivek Ramaswamy's LNP delivery tech play Genevant scores $600M licensing deal from Takeda for nucleic acid therapies

Endpoints

Mon, 03/15/21 - 11:10 am

Vivek Ramaswamy

lipid nanoparticles

JPM recap: Must-reads of the week, from FDA to IPO to M&A and more

Fierce Pharma

Fri, 01/11/19 - 10:25 am

Bristol-Myers Squibb

Teva Pharmaceutical

Pear Therapeutics